• J Magn Reson Imaging · Sep 2013

    Diffusion tensor imaging of normal-appearing white matter in unilateral cerebral arterial occlusive disease.

    • Xiangshui Meng, Qing Wang, Jinwen Hou, Xiaoming Zhang, Enguo Wang, Qilu Li, Qingshi Zeng, Qian Wang, Chuanfu Li, and Xiangxing Ma.
    • Department of Radiology, Qi Lu Hospital of Shandong University, Jinan, China.
    • J Magn Reson Imaging. 2013 Sep 1; 38 (3): 650-4.

    PurposeTo use MR with diffusion tensor imaging (DTI) and conventional and high b value to assess diffusion changes in normal-appearing white matter (NAWM) in patients with unilateral, severe stenosis, or occlusion of the middle cerebral artery (MCA).Materials And MethodsIn total, 28 patients with NAWM and unilateral, severe stenosis, or occlusion of the MCA underwent DTI with b values 1000 and 2200 s/mm(2) at 3.0T MR. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), radial diffusivity (eigenvalues λ1 , λ2 ), and axial diffusivity (eigenvalue λ3 ) were measured for the ipsilateral and contralateral corona radiata.ResultsMean FA was significantly lower for the ipsilateral than contralateral corona radiata with high b value, 2200 s/mm(2) , and ipsilateral corona radiata with conventional low b value, 1000 s/mm(2) (all P < 0.01). Mean ADC, λ1 , λ2 , and λ3 were significantly higher for the ipsilateral than contralateral corona radiata with high b value (all P < 0.05) but not for ipsilateral than contralateral corona radiata with low b value (P > 0.05).ConclusionDTI with a high b value detects diffusion changes in NAWM in patients with unilateral, severe stenosis, or occlusion of the MCA not seen with conventional b value or conventional MRI contrasts.Copyright © 2012 Wiley Periodicals, Inc., a Wiley company.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.